Infectious Disease Research Institute Inc.
Tampa, Florida, United States
Infectious disease physician in Tampa, Florida
4620 N Habana Ave #203, Tampa, FL 33614
About Infectious Disease Research Institute Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Infectious Disease Research Institute Inc.
During the past decade, Infectious Disease Research Institute Inc. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 11 clinical trials were completed, i.e. on
average, 366.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin
Completed
Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy
Completed
A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease
Completed
300
A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3
Completed
A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3
Completed
1,250
Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)
Completed
400
A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
1994-12-01
Completed
A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past
Completed
320
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Infectious Disease Research Institute Inc." #1 sponsor was "Gilead Sciences" with 10 trials, followed by "Abbott" with 4 trials
sponsored, "Bristol-Myers Squibb" with 4 trials sponsored, "Pharmacia and Upjohn" with 3 trials sponsored and "Glaxo Wellcome"
with 3 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Infectious Disease Research Institute Inc."
#1 collaborator was "Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Infectious Disease Research Institute Inc.
According to Clinical.Site data, the most researched conditions in "Infectious Disease Research Institute Inc." are
"HIV Infections" (26 trials), "HIV" (6 trials), "HIV-1 Infection" (2 trials), "Lipodystrophy" (2 trials) and "Chronic Hepatitis" (1 trials). Many other conditions were trialed in "Infectious Disease Research Institute Inc." in a lesser frequency.
Clinical Trials Intervention Types at Infectious Disease Research Institute Inc.
Most popular intervention types in "Infectious Disease Research Institute Inc." are "Drug" (35 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Zidovudine" (9 trials), "Lamivudine" (7 trials), "Stavudine" (4 trials), "ATV" (3 trials) and "Delavirdine mesylate" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Infectious Disease Research Institute Inc.
The vast majority of trials in "Infectious Disease Research Institute Inc." are
35 trials for "All" genders.
Clinical Trials Status at Infectious Disease Research Institute Inc.
Currently, there are NaN active trials in "Infectious Disease Research Institute Inc.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 32 completed trials in Infectious Disease Research Institute Inc.,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Infectious Disease Research Institute Inc., 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 23 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 4 trials that are defined as “Not Applicable".